Alterity Therapeutics Statistics
Total Valuation
PRNAF has a market cap or net worth of 79.15 million. The enterprise value is 52.35 million.
| Market Cap | 79.15M |
| Enterprise Value | 52.35M |
Important Dates
The last earnings date was Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 9.13B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +75.31% |
| Shares Change (QoQ) | +40.78% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.20 |
| PB Ratio | 2.85 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.57 |
| EV / Sales | 14.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.98 |
| Quick Ratio | 12.62 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.23% and return on invested capital (ROIC) is -32.43%.
| Return on Equity (ROE) | -43.23% |
| Return on Assets (ROA) | -28.09% |
| Return on Invested Capital (ROIC) | -32.43% |
| Return on Capital Employed (ROCE) | -34.50% |
| Revenue Per Employee | 396,200 |
| Profits Per Employee | -884,914 |
| Employee Count | 9 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PRNAF has paid 44,617 in taxes.
| Income Tax | 44,617 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.45% in the last 52 weeks. The beta is 0.36, so PRNAF's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +3.45% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 45.66 |
| Average Volume (20 Days) | 8,024 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PRNAF had revenue of 3.57 million and -7.96 million in losses. Loss per share was -0.00.
| Revenue | 3.57M |
| Gross Profit | 3.48M |
| Operating Income | -9.61M |
| Pretax Income | -7.92M |
| Net Income | -7.96M |
| EBITDA | -9.59M |
| EBIT | -9.61M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 26.66 million in cash and 101,919 in debt, giving a net cash position of 26.55 million.
| Cash & Cash Equivalents | 26.66M |
| Total Debt | 101,919 |
| Net Cash | 26.55M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.80M |
| Book Value Per Share | 0.00 |
| Working Capital | 27.76M |
Cash Flow
| Operating Cash Flow | -7.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 97.66%, with operating and profit margins of -269.57% and -223.35%.
| Gross Margin | 97.66% |
| Operating Margin | -269.57% |
| Pretax Margin | -222.10% |
| Profit Margin | -223.35% |
| EBITDA Margin | -269.05% |
| EBIT Margin | -269.57% |
| FCF Margin | n/a |
Dividends & Yields
PRNAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -75.31% |
| Shareholder Yield | n/a |
| Earnings Yield | -10.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRNAF has an Altman Z-Score of 1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 3 |